Thus, the sequencing data and IF/IHC staining let us deduce that despite the absence of 278 T > C mutations and a low frequency of 292 C > T mutations in the NES within our patients’ collective data, Survivin is nevertheless predominantly found in the nucleus of glioma cells. Here, BIRC5 is linked to central nervous system cancer.